Adjuvant antiviral therapy for recurrent respiratory papillomatosis
There's more to see -- the rest of this topic is available only to subscribers.
Citation
"Adjuvant Antiviral Therapy for Recurrent Respiratory Papillomatosis." Cochrane Abstracts, Evidence Central, evidence.unboundmedicine.com/evidence/view/Cochrane/439879/0/Risk_of_postoperative_infectious_complications_from_medical_therapies_in_inflammatory_bowel_disease_New. Accessed 23 April 2024.
Adjuvant antiviral therapy for recurrent respiratory papillomatosis. Cochrane Abstracts. https://evidence.unboundmedicine.com/evidence/view/Cochrane/439879/0/Risk_of_postoperative_infectious_complications_from_medical_therapies_in_inflammatory_bowel_disease_New. Accessed April 23, 2024.
Adjuvant antiviral therapy for recurrent respiratory papillomatosis. In Cochrane Abstracts https://evidence.unboundmedicine.com/evidence/view/Cochrane/439879/0/Risk_of_postoperative_infectious_complications_from_medical_therapies_in_inflammatory_bowel_disease_New
Adjuvant Antiviral Therapy for Recurrent Respiratory Papillomatosis [Internet]. In: Cochrane Abstracts. [cited 2024 April 23]. Available from: https://evidence.unboundmedicine.com/evidence/view/Cochrane/439879/0/Risk_of_postoperative_infectious_complications_from_medical_therapies_in_inflammatory_bowel_disease_New.
* Article titles in AMA citation format should be in sentence-case
TY - ELEC
T1 - Adjuvant antiviral therapy for recurrent respiratory papillomatosis
ID - 439879
BT - Cochrane Abstracts
UR - https://evidence.unboundmedicine.com/evidence/view/Cochrane/439879/0/Risk_of_postoperative_infectious_complications_from_medical_therapies_in_inflammatory_bowel_disease_New
DB - Evidence Central
DP - Unbound Medicine
ER -